| Primary |
| Product Used For Unknown Indication |
46.2% |
| Hypertension |
30.8% |
| Vertigo |
15.4% |
| Aortic Valve Replacement |
7.7% |
|
| Type 2 Diabetes Mellitus |
100.0% |
|
| Secondary |
| Product Used For Unknown Indication |
30.7% |
| Drug Use For Unknown Indication |
9.8% |
| Pain |
8.8% |
| Hypertension |
7.8% |
| Serum Ferritin Increased |
4.4% |
| Dizziness |
3.9% |
| Sideroblastic Anaemia |
3.9% |
| Breast Cancer |
2.9% |
| Chronic Myeloid Leukaemia |
2.9% |
| Gastritis |
2.9% |
| Hypothyroidism |
2.9% |
| Metastases To Bone |
2.9% |
| Prophylaxis |
2.9% |
| Restless Legs Syndrome |
2.9% |
| Deep Vein Thrombosis |
2.0% |
| Iron Overload |
2.0% |
| Vertigo |
2.0% |
| Aortic Valve Replacement |
1.5% |
| Laxative Supportive Care |
1.5% |
| Schizophrenia, Paranoid Type |
1.5% |
|
| Tubulointerstitial Nephritis |
9.1% |
| Ventricular Tachycardia |
9.1% |
| Vomiting |
9.1% |
| Pemphigus |
6.8% |
| Transaminases Increased |
6.8% |
| Type 2 Diabetes Mellitus |
6.8% |
| Urinary Tract Infection |
6.8% |
| Electrocardiogram Qt Prolonged |
4.5% |
| Gout |
4.5% |
| Joint Stiffness |
4.5% |
| Keratitis |
4.5% |
| Renal Failure Chronic |
4.5% |
| Tachyarrhythmia |
4.5% |
| Visual Field Defect |
4.5% |
| Accidental Overdose |
2.3% |
| General Physical Health Deterioration |
2.3% |
| Hypersensitivity |
2.3% |
| Hypokalaemia |
2.3% |
| Hyponatraemia |
2.3% |
| Hypothermia |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.8% |
| Prophylaxis |
16.1% |
| Drug Use For Unknown Indication |
13.7% |
| Hypertension |
9.1% |
| Diabetes Mellitus |
3.9% |
| Dizziness |
3.2% |
| Depression |
2.7% |
| Pain |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Hypothyroidism |
2.2% |
| Prophylaxis Of Nausea And Vomiting |
2.1% |
| Vertigo |
1.8% |
| Breast Cancer |
1.8% |
| Hypercholesterolaemia |
1.7% |
| Non-small Cell Lung Cancer |
1.7% |
| Osteoporosis |
1.6% |
| Renal Cell Carcinoma |
1.6% |
| Labyrinthitis |
1.5% |
| Nausea |
1.4% |
| Pain Prophylaxis |
1.4% |
|
| Hyponatraemia |
11.4% |
| Renal Failure Acute |
7.0% |
| Scleroderma |
7.0% |
| Hypomagnesaemia |
5.9% |
| Pulmonary Embolism |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| Urticaria |
5.4% |
| Progressive Multifocal Leukoencephalopathy |
4.9% |
| Swelling Face |
4.9% |
| International Normalised Ratio Increased |
4.3% |
| Myocardial Infarction |
4.3% |
| Vomiting |
4.3% |
| Dizziness |
3.8% |
| Thrombotic Thrombocytopenic Purpura |
3.8% |
| Tinnitus |
3.8% |
| Urinary Tract Infection |
3.8% |
| Weight Decreased |
3.8% |
| Gastrointestinal Perforation |
3.2% |
| Left Ventricular Hypertrophy |
3.2% |
| Loss Of Consciousness |
3.2% |
|
